Table 2 Characteristics of second round limiting dilution of shNef clones D2, B9 and F7
Clone | HIV-rtTA gDNA PCR | Intracellular CA-p24 (24 h) |
|---|---|---|
D2-1B | + | 0.10 |
D2-2C | + | 0.02 |
D2-4A | + | 0.01 |
D2-4B | + | 0.07 |
D2-5D | + | 0.04 |
D2-6D | + | 0.01 |
D2-6G | + | 0.04 |
D2-7F | + | 0.02 |
D2-8C | + | 0.04 |
D2-10D | + | 0.01 |
D2-12G | + | 0.01 |
B9-2F | + | 2.07 |
B9-2G | + | 0.12 |
B9-3H | + | 0.51 |
B9-4E | + | 0.71 |
B9-5F | + | 0.13 |
B9-11G | + | 0.29 |
F7-2B | + | 0.41 |
F7-3F | + | 0.2 |
F7-3G | + | 0.74 |
F7-4C | + | 0.22 |
F7-5F | + | 0.35 |
F7-5H | + | 0.11 |
F7-6B | + | 1.41 |
F7-6D | + | 69.05 |
F7-7G | + | 0.18 |
F7-8F | + | 14.30 |
F7-9D | + | 1.25 |
F7-10A | + | 0.11 |
F7-10E | + | 15.75 |
F7-10F | + | 0.28 |
F7-10G | + | 0.41 |